Recipient: Professor Bryan Day
Institute: QIMR Berghofer Medical Research Institute
Funding: $263,960 July 2016 to June 2019
Funding partner: This project is partially funded by a major donor of The Kids' Cancer Project
Childhood cancer treatment aims to get personal.
Medulloblastomas grow in the cerebellum. They are fast-growing, high-grade brain tumours which most commonly affect children, but can affect adults too. One of the major challenges in treating these patients is that individual cells within a single tumour mass are associated with different molecular characteristics. This leads to many different tumour behaviours along with variations in treatment response. Current diagnosis is unable to fully recognize this molecular diversity, nor can it provide information to guide appropriate treatment plans.

The project aims to address this issue among medulloblastoma patients by distinguishing tumour cells that survive standard therapies from those that are sensitive. The results from this research will allow researchers to identify patients who do not need aggressive treatments that cause chronic medical issues and to design and test therapies that could prolong patient survival.
“More research is urgently needed into this devastating disease. The Kids' Cancer Project is helping researchers like me to work towards better treatment options for children with brain cancer.” - Professor Bryan Day
Science is the solution for kids with cancer
The only way to improve outcomes for children diagnosed with cancer is through advances in medical research. Every day and every donation takes us closer to a cure.
Select your donation details
Please enter the amount you would like to donate

The Kids' Cancer Project is an ACNC Registered Charity 
ABN 13 061 138 181 | CFN 10581